Skip to main content

Sound Advice: July 1, 2020


Most Stocks Are Not Doing As Well As The Averages
It’s been a fascinating six months for the equity markets, especially considering how things changed when the market hit bottom on March 23rd.  Until that date, stocks such as Alphabet (a.k.a., Google) and Facebook were going nowhere fast.  Then the pandemic forced us to give up lives of flexibility and personal contact and shift to virtual life in the digital world.  Amazon, Facebook, and Netflix rose on a tidal wave of use.
It seems likely these beneficiaries will continue to prosper until the options we used to have are available again.  Their success, however, is not widely shared.
This is well illustrated by the comparison between the performance of the Standard & Poor’s 500 Index, which is capitalization-weighted, and the S&P 500 Index when measured on an equal-weighted basis.
Let me explain the difference.  The index as stated includes companies of all sizes.  Some are huge; others are tiny.  When the shares of the biggest companies rise or fall, the impact on the index could be 100 times or more than the price movement of the smallest companies.
Think of a circus with 500 animals, including elephants and monkeys.  Which do you think would carry the most weight?  It’s the same with the S&P 500 Index.
When the index is viewed on an equal-weighted basis, the impact of each of the companies is identical, regardless of size.
The comparison between the cap-weighted and equal-weight indexes is striking.
Over the last six months (essentially year to date), the cap-weighted S&P 500 index fell by 6%.  The equal-weighted index dropped by 15%.  In other words, most stocks are way behind the market.  
What are often referred as blue chips have done even worse.  Banks such as J.P. Morgan, Bank of America, and Citi are all down by more than 30%.  And then there’s AT&T, which lost 26%.
The quarters ahead will certainly be filled with further market volatility, sparked by interim reports of employment, unemployment claims, corporate earnings, actions by the Federal Reserve, campaigns for the upcoming presidential election, as well as progress in the battle against the COVID virus.  More likely than not, prices will bounce around through a broad, extended trading range while we wait for good news about therapeutics and vaccines.
Although we continue to deal with a bombardment of doom and gloom, the passing of each day gets us closer to the medical breakthroughs needed.

N. Russell Wayne, CFP®

Comments

Popular posts from this blog

Sound Advice: May 13, 2020

Reality Check

On the heels of the market plunge of late February and most of March, investors did a sharp about-face in April, bidding up shares at one of the fastest rates in recent history.  Although this recovery probably provided at least temporary comfort from the plunge, it would be unreasonable to view the rebound as a sign that things are all better.  They are not.
For one thing, we are now in the midst of earnings reason, when companies report their quarterly results.  Some may have good news for the March quarter, but as we move through the current calendar quarter, only a few will be able to show continuing improvement.  Against the broad backdrop of U.S. business history, the months just ahead will almost certainly prove to be among the worst, from the standpoint of year-to-year comparison.
With more than 30 million people filing claims for unemployment insurance, it would be difficult to expect anything other than bad economic news.  Who knows how many of these folks will go…

Sound Advice: July 15, 2020

Insurance
“An ingenious modern game of chance in which the player is permitted to enjoy the comfortable conviction that he is beating the man who keeps the table.” Ambrose Bierce
One can only marvel at the broad scope of insurance schemes created in the pursuit of fat commissions for insurance agents.  From the simplest plans, such as whole life, to the ultracomplex, which no one understands but promises to provide rewards beyond one’s wildest dreams, it’s an area where fear and greed work together to soften the brain of the buyer and enrich the pocketbook of the seller.  
There are certainly risks requiring the protection of properly selected insurance, but the range of products developed to generate hefty ongoing profits is ever-expanding.  The industry continues its efforts to stay ahead of people who are struggling to understand what these products are and why they need them.
One example is life insurance, which has numerous permutations.  Life insurance is needed to provide protection…

Sound Advice: June 17, 2020

Rock and a Hard Place Regardless of your age, impressions from childhood linger.  As the first days of summer approach, we all remember the feeling that accompanied the end of a school year.  Yet as much as many of us would like to believe we again have the summertime freedom to do as we wish, the reality is quite the opposite. Although months of confinement and limitations on social interaction have increased our personal discomfort and severely impacted the business community, our current situation is not analogous to the end of any school year.  It’s quite the opposite. There is every reason to continue wearing face masks, social distancing, and avoiding close contact with others.  Nothing suggests that we can modify our behavior significantly or resume patterns of daily living we enjoyed only a few months ago. There are no meaningful advances in medical treatments.  At best, there are attempts to combine different approaches that might speed up recovery.  The hoped-for vaccines are st…